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Background: A number of clinical trials have encountered difficulties enrolling a sufficient number of patients
upon initiating the trial. Recently, many screening systems that search clinical data warehouses for patients who are
eligible for clinical trials have been developed. We aimed to estimate the number of eligible patients using routine
electronic medical records (EMRs) and to predict the difficulty of enrolling sufficient patients prior to beginning a
trial.
Methods: Investigator-initiated clinical trials that were conducted at Kyoto University Hospital between July 2004
and January 2011 were included in this study. We searched the EMRs for eligible patients and calculated the
eligible EMR patient index by dividing the number of eligible patients in the EMRs by the target sample size.
Additionally, we divided the trial eligibility criteria into corresponding data elements in the EMRs to evaluate the
completeness of mapping clinical manifestation in trial eligibility criteria into structured data elements in the EMRs.
We evaluated the correlation between the index and the accrual achievement with Spearman's rank correlation
coefficient.
Results: Thirteen of 19 trials did not achieve their original target sample size. Overall, 55% of the trial eligibility
criteria were mapped into data elements in EMRs. The accrual achievement demonstrated a significant positive
correlation with the eligible EMR patient index (r = 0.67, 95% confidence interval (CI), 0.42 to 0.92). The receiver
operating characteristic analysis revealed an eligible EMR patient index cut-off value of 1.7, with a sensitivity of
69.2% and a specificity of 100.0%.
Conclusions: Our study suggests that the eligible EMR patient index remains exploratory but could be a useful
component of the feasibility study when planning a clinical trial. Establishing a step to check whether there are
likely to be a sufficient number of eligible patients enables sponsors and investigators to concentrate their
resources and efforts on more achievable trials.
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Clinical trials are essential for gaining and extending
knowledge about new therapies, and sufficient patient
enrollment in clinical trials is critical to fulfill their sci-
entific objectives. Nevertheless, a number of trials have
failed to achieve their target sample size within the ori-
ginal accrual period [1-3]. For such trials, extending the
accrual period, modifying the eligibility criteria or, in the
worst case scenario, prematurely closing the trial may be
necessary. Moreover, many investigators continue to
make the same mistakes despite the great advances
made in handling clinical trials data using information
technology [4].
Many reasons for the low levels of recruitment have
been cited, including fewer eligible patients than ex-
pected, a smaller percentage of patients agreeing to par-
ticipate [1,5], time constraints, resource issues, consent
interviews and difficulties in identifying the patients [6].
Recently, many screening systems that search elec-
tronic medical records (EMRs) or clinical data ware-
houses derived from EMRs for patients eligible for
clinical trials have been developed, and their efficiencies
have been evaluated [7-9]. The number of patients who
meet the eligibility criteria when medical records are
manually reviewed is less (13 to 74%) than the number
of potential trial patients identified by an electronic
screening system [7,10-15]. Nevertheless, screening sys-
tems are promising in that they can provide information
on the total eligible patient population at the planning
stage of a clinical trial. Estimates of the number of eli-
gible patients enable both the sponsors and the investi-
gators to concentrate their resources and efforts on
more achievable and conclusive trials. Moreover, investi-
gators should not put their patients at risk by enrolling
them in an inconclusive trial. For more reasonable re-
search programs, we hypothesized that researchers can
predict the difficulty of trial patient enrollment by esti-
mating the number of eligible patients using EMR data.
We explored how to estimate the number of eligible pa-
tients using the EMRs, and using a retrospective design,
we tested our hypothesis that the number of eligible pa-
tients identified from EMRs correlates with the number
of patients actually enrolling in clinical trials.
Methods
Trial data collection
The trials were identified using a departmental database
from the Institute for Advancement of Clinical and
Translational Science and the University Hospital Med-
ical Information Network Clinical Trial Registry (UMIN-
CTR) [16]. The investigator-initiated therapeutic trials
that started between July 2004 and January 2011 were
included if the following data were available: the trial eli-
gibility criteria, target sample size, number of enrolledpatients and accrual period at the Kyoto University Hos-
pital (KUH). The trial eligibility criteria, number of
scheduled and enrolled patients and the duration of en-
rollment were extracted from published papers or from
registered information in the UMIN-CTR. For unpub-
lished data, trial protocols and management lists in the
departmental database were used after obtaining consent
from the relevant principal investigators. The study
protocol was approved by the Ethical Committee of the
Graduate School of Medicine, Kyoto University (E1175).
Electronic medical records retrieval system
We used an EMR retrieval system that was developed at
the Institute for Advancement of Clinical and Transla-
tional Science to screen EMRs for patients in KUH [17].
In this system, EMR data, including diagnoses, medica-
tions and injections, laboratory tests, radiological or
pathological studies, and operative notes, were extracted
from the data warehouse to enable the comprehensive
and efficient retrieval of patient data.
The replacement of trial eligibility criteria with patient
characteristics for a comparison to electronic medical
records
We replaced the trial eligibility criteria of the trial proto-
col with patient characteristics that could be easily com-
pared with EMR data and matched the translated
criteria with the data elements in EMRs, referencing the
methods of previous studies [10,11,17-21].
After the trial eligibility criteria were collected, three
physicians discussed and replaced concepts in the eligi-
bility criteria of each trial with patient characteristics,
which were represented by codes, fixed terms or nu-
meric data. Some medical concepts, such as ‘severe heart
disease’, may be interpreted differently depending on the
trial and the clinician caring for the patients. The three
physicians discussed these concepts and made a general
list of how to interpret these concepts as patient charac-
teristics, such as considering a particular concept to be
part of a group of diagnoses. The list also included in-
structions on how to replace the specific medical condi-
tions that do not directly indicate one or more data
elements in the EMRs by the data elements in the EMRs
related to the conditions. For instance, we replaced the
criterion ‘patients who do not need intravenous hyperali-
mentation’ with ‘no order for high-calorie infusion’.
Namely, we aimed to estimate the number of patients
who were already receiving care from the trial treatment
or from alternative treatments in routine clinical practice
rather than estimating the potential number of eligible
patients still at the diagnostic stage. Concurrently, we
re-categorized the eligibility criteria of the trial protocol
into three categories: ‘Select’, ‘Omit’ and ‘Not applicable’.
The ‘Select’ category indicates that the patient was
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category indicates that the patient was excluded if he or
she fulfilled the condition but was not excluded if the
data were not available or were missing. The ‘Not applic-
able’ category indicates that the criterion cannot be
searched in the EMRs because of missing or incomplete
EMR data; for instance, the data were entered in plain-
text freely, were captured as an image or were not en-
tered. Thus, the items in the ‘Not applicable’ category
were neither translated into computable eligibility cri-
teria nor searched for in the EMRs.
Laboratory test requirements were indicated in either
the inclusion or exclusion items of the trial eligibility cri-
teria. If the laboratory tests were routinely performed,
the requirements of the laboratory tests were categorized
as 'Select', and if the test result fulfilled the requirement
at least once, the patients were deemed eligible. If the
tests were not performed routinely, the requirements of
the laboratory tests were categorized as 'Omit'.
The periods of the order or the records to search were
critical for estimating the number of patients. We searched
for eligible patients using a primary criterion that was re-
corded during the year for which we wanted to know the
number of eligible patients. For the other criteria, such as
acute illness or diseases with no prior therapy, we searched
eligible patients with other criteria in addition to the pri-
mary criterion recorded during the preceding two years
for acute illness or diseases with no prior therapy and the
previous five years for chronic or recurrent disease.
The degree of concordance with the electronic medical
record data
We examined how many and what type of trial eligibility
criteria were mapped into the patient characteristics and
corresponding data elements of the EMRs to evaluate
the completeness of our mapping. We assigned patient
characteristics, as mentioned above, to one of the 27 se-
mantic categories defined by Luo et al. [22]. One author,
a medical doctor, broke up and assigned the eligibility
criteria to one of the semantic categories, and another
medical doctor validated the results. Then, we counted
the number of patient characteristics in the ‘Select’ or
‘Omit’ and ‘Not applicable’ categories.
The number of eligible patients in the electronic medical
records
We searched for potentially eligible patients using the
EMR retrieval system. Each query in the EMR retrieval
system was tested to find errors both in the program
and in the search results. A system engineer then exam-
ined the number of patients in the ‘Select’ category, the
‘Select’ but not the ‘Omit’ category and the ‘Select’ and
‘Omit’ categories to confirm that the first number was
equal to the sum of the second and third numbers. Afterthis test, he obtained the estimated number of poten-
tially eligible patients both in the year preceding the
start of a trial and in the year in which a trial started
using the EMR retrieval system. We did not perform an
additional manual review of the medical records after
the data extraction.
Statistical analysis
The target sample size, number of patients actually en-
rolled, scheduled accrual period and actual accrual
period were obtained.
The following formula was used to determine the eli-
gible EMR patient index and the accrual achievement:
The eligible EMR patient index = the number of eligible
patients identified by the EMRs per year/the target
sample size per year.
The accrual achievement = the number of enrolled
patients per year/the target sample size per year.
Where, the target sample size per year = the target
sample size at KUH/the scheduled accrual period (year).
The number of enrolled patients per year = the number
of patients actually enrolled at KUH/the actual accrual
period (year).
We examined the relationship between the eligible EMR
patient index and the accrual achievement using Spear-
man's rank correlation coefficient. The receiver operating
characteristic (ROC) curves were used to determine the
cut-off value for the eligible EMR patient index that iden-
tified the low enrollment trials with accrual achievements
<1.0. Furthermore, we examined the consistency between
the numbers of searched eligible patients in the year pre-
ceding the start of a trial and in the year in which a trial
began to evaluate the reliability of the eligible EMR patient
index. All statistical analyses were performed using R-
2.14.1 and SAS software for Windows.
Results
Trial information
Of the 24 trials screened, 15 trials in the Institute for
Advancement of Clinical and Translational Science data-
base met the inclusion criteria, in addition to four trials
in the UMIN-CTR (accessed on May 2, 2011). Table 1
indicates the characteristics of the 19 trials. The patient
accrual period was extended in seven trials, and six trials
recruited 100% or more of their target sample size
within the scheduled accrual period.
The replacement of trial eligibility criteria with patient
characteristics for comparisons with the electronic
medical records
We replaced and matched the trial eligibility criteria for
the 19 trials with the data elements in the EMRs. We
Table 1 Characteristics of the trials















2004 to 2005 3
2006 to 2007 10
2008 to 2009 3
2010 3
Target sample size per year per centera
0 to 9 6
10 to 19 6
20 to 29 2
30 to 39 1
≥40 4
Enrolled patients per year per center
0 to 9 10
10 to 19 3
20 to 29 1
30 to 39 4
≥40 1
aThe target sample size was calculated as the total sample size divided by the
number of centers in a single trial for which an assigned sample size was not
determined. KUH, Kyoto University Hospital.
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domized controlled study of the effectiveness of trans-
catheter arterial chemoembolization with cisplatin and
transcatheter arterial chemoembolization with epirubicin
for multiple hepatocellular carcinomas’ (Figure 1). The
trial candidates were patients who were to receive trans-
catheter arterial chemoembolization for multiple HCCs
at stage 2 to 4a without thrombosis in the portal vein,
hepatic vein and the bile duct, although the trial eligibil-
ity criteria were only presented as the disease conditions.
Therefore, we replaced the disease condition with the re-
lated standard treatment for the patients and assessedthe radiologic study order in EMRs to narrow down the
trial candidates.
The degree of matching with the electronic medical
record data
The 318 eligibility criteria from the 19 trials were trans-
formed into 425 patient characteristics. Of the 425 pa-
tient characteristics, 408 were related to 18 semantic
categories, and 17 were related to a ‘ no fitting category’.
We found that 55% (235 of 425) of the characteristics in
the eligibility criteria were matched with data elements
in the EMRs. Compared with a previous study by
Kopcke et al. [21], the degree of matching was similar
with respect to both the total and the category (Table 2).
The degree of match for each trial ranged from 38% to
75% (median 54%), and the degree was 50% in three
trials.
Data retrieval, correlation and receiver operating
characteristic analysis
We searched the EMRs for patients who fit the comput-
able criteria characteristics in the 19 trials, counted the
number of patients in each trial and calculated the eli-
gible EMR patient index. The accrual achievement dem-
onstrated a significant positive correlation with the
eligible EMR patient index (r = 0.67, 95% confidence
interval (CI), 0.42 to 0.92; Figure 2). The ROC analysis
revealed an estimated 1.7 cut-off value for the eligible
EMR patient index, with an area under the curve (AUC)
of 0.846, a sensitivity of 69.2% and a specificity of
100.0% (Figure 3). None of the nine trials for which the
eligible EMR patient index was less than 1.7 achieved
their original target sample size within the scheduled ac-
crual period. There were 16 trials in which 50% or more
of trial criteria were matched with the data elements in
the EMRs. The relationship of the eligible EMR patient
index and the accrual achievement in these 16 trials also
exhibited a positive correlation (r = 0.67, 95% CI, 0.38 to
0.96). The ROC analysis revealed an estimated 1.7 cut-
off value for the eligible EMR patient index, with an
AUC of 0.867, a sensitivity of 70.0% and a specificity of
100.0%.
The number of identified eligible patients in the year
preceding the start of the trial was almost consistent
with the number of identified eligible patients in the year
in which a trial began (Figure 4). The median ratio of
the number of eligible patients in the preceding year to
the number in the year a trial began was 1.00 (range,
0.36 to 1.67).
Discussion
We developed a formula to estimate the number of eli-
gible patients using routine EMR data. In half of the
tested trials, using the eligible EMR patient index, we
Trial eligibility criteria
•Key inclusion criteria
2)Patients with multiple HCCs that are diagnosed as stage2-4a and cannot be selected for surgical resection or local ablation
3)Patients without severe tumor thrombosis in the portal vein, hepatic vein or bile duct 
4)Patients under Child-Pugh A or B 
5)Patients under PS 0 or 1  
6)Patients who fulfill all selected criteria : WBC>=3000/mm3, Plt>=5x10^4/mm3, … 
7)Patients who are 20 years and older
•Key exclusion criteria
1)Patients with another active cancer 
2)Patients with extrahepatic metastases 
3)Patients with prior surgical reconstruction of the biliary tract or prior endoscopic treatment of ampulla of vater 
4)Patients with clinically significant refractory ascites or pleural effusion 
5)Patients with a medical history of severe hypersensitivity
Patient characteristics
•Select
1)Patients with an HCC diagnosis
2)3) Patients who are going to receive transcatheter arterial chemoembolization for multiple HCCs
4)5)Not applicable
6)Patients who fulfill all selected criteria at least once: WBC>=3000/mm3, Plt>=5x10^4/mm3,… 
7)Patients who are 20 years and older
•Omit
1)Patients with a diagnosis of another active cancer 
2)Patients with a diagnosis of extrahepatic metastasis 
3)Patients with prior surgical reconstruction of the biliary tract or prior endoscopic treatment of the ampulla of 
vater 
4)Patients with a diagnosis of significant refractory ascites or pleural effusion 
5)Patients with a diagnosis of severe hypersensitivity
Data elements in EMRs
Criterion Section Code or definition Parameter
•Select
1) Diagnosis ICD10 Code ‘C220’
2)3) Radiologic study Order name ‘TAI’ or ‘TAE’
6) Laboratory tests WBC >=3000/mm3
6) Laboratory tests Plt >=5x10^4/mm3
7) Demographics age >=20
•Omit
1)2) Diagnosis ICD10 Code ‘C001’, ‘C003’, …according to the list,  except 
for ‘C220’
3) Operative notes ICDCM or surgical procedure ‘509078‘, ‘509079‘, … or surgical procedure= 
‘partial biliary tract resection’…
4) Diagnosis ICD-10 codeor diagnosis ‘pleural effusion (refractory)’ or ‘refractory pleural 
effusion’  and so on
5) Diagnosis ICD-10 code ‘T781’,’T887’
Replace
Matching
1)Patients with histologically or clinically confirmed HCC 
Figure 1 An example of replacement of trial eligibility criteria with patient characteristics for comparisons with the electronic medical
records (EMRs). The trial eligibility criteria, replaced patient characteristics and matched data elements of EMRs are presented in the first, second
and third columns, respectively. HCC, hepatocellular carcinoma; PS, performance status; TAE, transcatheter arterial embolization; TAI, transcatheter
arterial infusion chemotherapy.
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the trial would have a low enrollment because of fewer
than expected eligible patients. If researchers are able to
accurately predict a shortage of eligible patients, they
may modify the eligibility criteria, recruit more partici-
pating institutions or abandon the trial to avoid wasting
funds and efforts as well as exposing patients to un-
necessary risk.
A number of screening methods for EMRs for eligible
patients have been developed [7,8,10,11,18-20]. The
search method for eligible patients used in our study
was based on the patient treatment information rather
than the plain text description of the disease in the
EMRs. Although we may underestimate the number of
potentially eligible patients who were diagnosed with the
target disease without standard therapy, we consider
those patients to be patients without active disease, pa-
tients who are unable to be treated or patients who are
unwilling to be treated. Thus, there is little chance to en-
roll these patients into a clinical trial. When there is no
standard therapy for the target disease or the targetstage of the disease, one must review the text in the
EMRs manually or incorporate an adequate text mining
technology to improve the search precision. However,
we speculated that the combination of a diagnosis with
other information may help refine the estimation [23],
and we found that the EMR data and the estimation of
the number of patients were accurate enough to predict
some of the low enrollment trials.
Approximately one-half of all patient characteristics
replaced from the trial eligibility criteria were matched
with data elements in EMRs. Considering that the de-
gree of matching in total or by category was not inferior
to that achieved in a previous study [21], the included
19 trials are not biased, despite their small number.
However, 45% of the patient characteristics were not
matched with data elements in the EMRs, which may
lead to an overestimation or underestimation of the num-
ber of eligible patients in the EMRs. Some trial criteria,
such as ‘pregnant or lactating’, ‘measurable disease by
RECIST’ and ‘New York Heart Association class I’, were
classified as ‘Not applicable’ and were not considered
Table 2 Degree of translation to the electronic medical record (EMR) data
Patient characteristics Data elements in EMRs Degree of translationa Previous studyb
Health status 236 141 0.61 0.60
Disease, symptoms and signs 120 80 0.68 0.81
Pregnancy-related activity 12 0 0 0.16
Neoplasm status 24 16 0.67 0.75
Disease stage 10 1 0.10 0.25
Allergy 12 4 0.33 0.17
Organ or tissue status 54 40 0.75 0.74
Life expectancy 4 0 0 0
Treatment or healthcare 45 24 0.55 0.57
Pharmaceutical substance or drug 26 10 0.40 0.35
Therapy or surgery 19 14 0.74 0.74
Device 0 0 NA 0
Diagnostic or lab results 84 47 0.56 0.54
Diagnostic or lab results 84 47 0.56 0.54
Receptor status 0 0 NA 0
Demographics 21 21 1.00 0.85
Age 20 20 1.00 0.95
Special patient characteristic 0 0 NA 0.33
Literacy 0 0 NA 0
Gender 1 1 1.00 1.00
Address 0 0 NA 0
Ethnicity 0 0 NA 0
Ethical consideration 12 0 0 0.08
Consent 8 0 0 0.06
Enrollment in other studies 1 0 0 0
Capacity 2 0 0 0.16
Patient preference 1 0 0 0
Compliance with protocol 0 0 NA 0
Lifestyle choice 10 0.20 0.82
Addictive behavior 5 0 0 0.90
Bedtime 0 0 NA 0
Exercise 0 0 NA 0
Diet 5 2 0.40 0
No fitting category 17 0 0 -
Total 425 235 0.55 0.55
aThe degree of translation = the number of patient characteristics/the number of data elements in EMRs.
bPrevious study: the fraction of documentable patient characteristics in previous study [21]. The authors calculated the fraction of patients with any data in at
least one corresponding data element for each patient characteristic.
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cluded. In addition, the diagnosis in the EMRs does not
necessarily reflect the current condition of the patient.
Temporary diagnoses or diagnoses related to the payment
of medical insurance are often included in the EMRs and
provide false or misleading information that leads to over-
estimating the number of eligible patients in the EMRs.
However, because the exclusion of three trials with lowlevels of matching did not change the result of the correl-
ation analysis or the ROC analysis, the impact of low
levels of matching did not seem to be substantial.
In addition, the eligible EMR patient index is necessary
but not sufficient to predict low levels of recruitment.
Disappointingly, approximately half (four of ten) of the
trials with an eligible EMR patients index greater than
1.7 resulted in low enrollment in this study. This finding












Figure 2 Correlation between the eligible electronic medical
record (EMR) patient index and the accrual achievement in 19
trials. The eligible EMR patient index = the number of eligible
patients identified from the EMRs per year/target sample size per
year. The accrual achievement = the number of enrolled patients per
year/target sample size per year.
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Figure 4 A plot of the number of searched eligible patients
both in the year preceding and the year following the opening
of a trial.
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patients and from the inaccuracy of EMR data. For in-
stance, only 51% of the eligible patients agreed to par-
ticipate in a cancer trial at one university-based cancer
center [24]. Indeed, the consent rates in the trials con-
ducted in our center ranged from 25% to 100% (data not
shown). Four times as many patients as the number of
eligible patients in EMRs are necessary when the con-
sent rate of the trial is 25%. Therefore, investigators
should consider other disincentive factors that wouldFigure 3 The receiver operating characteristic (ROC) analysis of
the eligible electronic medical record (EMR) patient index in
19 trials.empirically influence a patient’s consent, such as foresee-
able risks or inconveniences to the patients, and the in-
vestigators can then determine whether the trial would
in fact achieve its target sample size.
Our method also excluded a manual review of the
EMRs. In previous studies, the eligible patients were
generally identified by the EMRs in two steps: (1) the pa-
tient characteristics were screened and matched with
standardized codes (for example, ICD codes) or numeric
data; and (2) the medical records were manually recon-
firmed by the medical staff [10,11]. Our aim was to ob-
tain the total number of eligible patients instead of
examining whether an individual patient was eligible for
the trial. Therefore, we did not confirm whether the pa-
tients searched by the EMR retrieval system were eligible
for the trial by verifying the entirety of their EMR data.
As a result, the privacy of patients who had not given
consent to participate in the trial is protected, while in-
vestigators can still speculate on the feasibility of the
trial protocol.
The estimated number of eligible patients during the
year of the trial accrual period did not exhibit a substan-
tial increase compared to that of the preceding year. Re-
searchers were unable to enroll more patients than they
routinely cared for, regardless of the intensity of the re-
cruitment efforts. The acquisition of new patients may
be difficult because of the high degree of development
among medical institutions and the guaranteed access by
Japanese patients to any institution under the compre-
hensive medical insurance system. Additionally, most
patients in Japan would have already been diagnosed or
treated by specialists in a branch of medicine [25].
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‘replacement’ was not the exact translation of the trial
eligibility criteria into data elements in the EMRs and in-
stead depended on physicians’ conception or the informa-
tion presented in the trial protocol; thus, disagreement
concerning the replacement or incomplete replacement
may occur. Another limitation is that the eligible EMR pa-
tient index cannot predict all trials that will result in a fail-
ure of accrual (sensitivity, 0.645). The index is designed
for a single institution and for a relatively small number of
target trials. The cut-off value of the eligible EMR patient
index in another institution may be different from ours.
To speculate whether there are enough potentially eligible
patients at a participating trial site for a multicenter clin-
ical trial, each site must be equipped with an efficient
EMR retrieval system. Moreover, this study was explora-
tory in nature, and prospective studies would be needed
to validate the predictive ability of the eligible EMR pa-
tient index for future clinical trials.
Conclusions
Our study suggests that in addition to the knowledge of
experienced investigators, the health information in
EMRs could be a useful component of the feasibility
study when planning a clinical trial. Establishing a step
to check whether there are likely to be a sufficient num-
ber of eligible patients enables sponsors and investiga-
tors to concentrate their resources and efforts on more
achievable trials.
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